It is a pharma public limited company based in Thane, Maharashtra, India, established in 1997.
1997 | Thane, Maharashtra, India | ActiveBansal Pharma Limited, a active public limited company, was established on 11 September 1997 in Thane, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24200MH1997PLC110599. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Sajankumar Rameshwarlal Bajaj (Director), Anil Champalal Jain (Director), Namrata Sajankumar Bajaj (Additional Director). Past directors included Dhananjay Hatle Sabaji, Ajit Ambalal Shah, Gopal Vaikunthlal Mehta. It holds no open charges and ₹2.78 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 602-606,Bhoomi Velocity Infotech Park, Plot No.B-39,39A,39A/1,Rd No.23,Wagle In, D. Estate, Thane, Maharashtra, 400604.
U24200MH1997PLC110599
110599
11 September 1997
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bansal Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sajankumar Rameshwarlal Bajaj | Director | 01 Apr 1998 | Current |
| Anil Champalal Jain | Director | 31 Jul 1999 | Current |
| Namrata Sajankumar Bajaj | Additional Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Jun 2025 | Past |
| Pramod Abcsdd | Director | 31 Jan 2008 | Past |
| Pramod Abcsdd | Director | 28 Aug 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bansal Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 127.92% increase. The company also saw a substantial fall in profitability, with a 141.06% decrease in profit. The company's net worth dipped by a decrease of 1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bansal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹27,830,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2004 | The Saraswat Co-Operative Bank Ltd | ₹7.50 M | Satisfied |
| 04 Nov 1999 | The Saraswat Co-Operative Bank Ltd | ₹0.33 M | Satisfied |
| 23 Aug 1999 | Corporation Bank | ₹1.00 Cr | Satisfied |
| 23 Aug 1999 | Corporation Bank | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bansal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bansal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bansal Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Namrata Sajankumar Bajaj was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 9 months 18 days . was completed.
Progress on Bansal Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
A charge registered on 23 Aug 1999 via Charge ID 90142508 with Corporation Bank was fully satisfied on 31 Aug 2007. was recorded as a recent event.
The activity A charge registered on 23 Aug 1999 via Charge ID 90147332 with Corporation Bank was fully satisfied on 31 Aug 2007. was completed.
The activity A charge registered on 20 Feb 2004 via Charge ID 90148579 with The Saraswat Co-Operative Bank Ltd was fully satisfied on 20 Jul 2007. was completed.
The CIN of Bansal Pharma Limited is U24200MH1997PLC110599.
Bansal Pharma Limited is headquartered at 602-606,Bhoomi Velocity Infotech Park, Plot No.B-39,39A,39A/1,Rd No.23,Wagle In, D. Estate, Thane, Maharashtra, 400604.
Bansal Pharma Limited was incorporated on 11 September 1997.
The current directors of Bansal Pharma Limited are
The primary industry of Bansal Pharma Limited is Trade.
Bansal Pharma Limited is unlisted.
The authorized capital of Bansal Pharma Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Bansal Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX